Dr. Carrie K. Jones is a neuropharmacologist and an Associate Professor of Pharmacology at Vanderbilt University. Dr. Jones’s research interests focus on the in vivo effects of metabotropic glutamate receptor and muscarinic acetylcholine receptor ligands in the regulation of brain function and behavior. Her research also includes the development of selective M1 positive allosteric modulators for the treatment of age-related impairment in cognition and sleep architecture observed in Alzheimer’s disease. Dr. Jones is an investigator in the Vanderbilt Alzheimer’s Disease Research Center.
Dr. Jones completed her doctoral degree in medical neurobiology at Indiana University School of Medicine, a postdoctoral fellowship in pharmacology at Lilly Research Laboratories, and a postdoctoral fellowship in pharmacology at Vanderbilt University Medical Center. She joined the Vanderbilt faculty in 2007.